# Morphine

## Morphine inj 10mg/1mL

##### 

| TAH Drug Code      | [IMORP](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IMORP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Relief of moderate to severe pain. Pre-op anesth.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | SC/IV Opiate agonist naive patients Initially 2-5 mg every 3-4 hours. Higher dose may be used for patients used before. 0.8-10 mg/hr by continuous infusion. Patient with assisted ventilation (for 70 kg body weight) 0.7-10 mg IV per 1-2 hour or 5-35 mg/hr as continuous infusion. Epidural: 1-5 mg as single dose. Continuous infusion: Initially 1-5 mg at rate of 0.1-1 mg/hr. Subarachnoid injection: Opiate agonist naive patients 0.1-0.3 mg each time to provide 24 hours relief. Not recommended to repeat dose. Pain relief of surgical anesthesia: adjust dose according to age & symptoms. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Respiratory depression, head injury, obstructive airways disease, paralytic ileus, GI obstruction, delayed gastric emptying, acute hepatic disease. Use within 2 weeks of MAOI therapy. Not recommended during pregnancy & in children < 3 years.                                                                                                                                                                                                                                                                                                                                                         |
| Adverse Effects    | Nausea, vomiting, constipation, drowsiness, palpitations, headache, disorientation, vertigo, mood changes, decreased libido, ureteric spasm, urinary retention, rash, sweating, facial flushing, miosis.                                                                                                                                                                                                                                                                                                                                                                                                  |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

## Morphine 15mg

##### 

| TAH Drug Code      | [OMOR1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OMOR1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Relief of moderate to severe pain. Pre-op anesth.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Dosing             | 5-30 mg every 4 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | Respiratory depression, head injury, obstructive airways disease, paralytic ileus, GI obstruction, delayed gastric emptying, acute hepatic disease. Use within 2 weeks of MAOI therapy. Not recommended during pregnancy & in children < 3 years.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Nausea, vomiting, constipation, drowsiness, palpitations, headache, disorientation, vertigo, mood changes, decreased libido, ureteric spasm, urinary retention, rash, sweating, facial flushing, miosis. Cardiovascular: Peripheral edema (5% to 10% ) Dermatologic: Pruritus (up to 80% ), Rash (5% to 10% ), Sweating (5% to 10% ) Gastrointestinal: Abdominal pain (5% to 10% ), Constipation (> 10% ), Diarrhea (5% to 10% ), Loss of appetite (5% to 10% ), Nausea and vomiting (7% to 70% ), Xerostomia (5% to 10% ) Hepatic: Liver function tests abnormal (< 5% ) Musculoskeletal: Backache (5% to 10% ) Neurologic: Asthenia (5% to 10% ), Dizziness (6% ), Headache (>10% ), Insomnia (5% to 10% ), Lightheadedness, Paresthesia (5% to 10% ), Somnolence (> 10% ) Ophthalmic: Amblyopia (< 5% ), Miosis Psychiatric: Anxiety (6% ), Depression (5% to 10% ) Renal: Urinary retention (oral: < 5% ; epidural/intrathecal: 15% to 70% ) Other: Fever (5% to 10% ), Hiccoughs (< 5% ) |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

